Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Eye Tracking May Be Key to Detecting & Treating Concussions, Brain Injuries

  • Broadcast in Health
Faces of TBI

Faces of TBI

×  

Follow This Show

If you liked this show, you should follow Faces of TBI.
h:942153
s:11152789
archived

Dr. Uzma Samadani founded Oculogica in 2013, and her laboratory has developed the eye-tracking methodology and published six papers on its utility. She is currently the Rockswold Kaplan Endowed Chair for Traumatic Brain Injury at Hennepin County Medical Center and Associate Professor of Neurosurgery at the University of Minnesota. She serves on the American Association of Neurological Surgeons/Congress of Neurological Surgeons Executive Committee for Trauma and Critical Care and is Scientific Program Chair of the AANS/CNS National Neurotrauma Society Joint Satellite Meeting.

Rosina Samadani is the CEO of Oculogica and has 20 years of experience with medical device companies, including 7 years with McKinsey & Company as a leader in their healthcare practice. She holds a PhD in Biomedical Engineering from Northwestern University and BS and MS in Mechanical Engineering from MIT.

Oculogica a medical device company dedicated to developing breakthrough technology to fundamentally transform the diagnosis of concussions and Traumatic Brain Injuries with its non-invasive, fast, patent-protected and peer-reviewed technology. 

www.oculogica.com 

Comments